APOA1 and myeloid sarcoma: In the present study, we estimated that 0.66 (sensitivity 70.1%, specificity 57.8%) and above is an adjusted optimal cutoff point for the ApoB/ApoA1 ratio for discriminating subjects with and without MS after controlling for potential confounding factors in the Kazakh population.